Medy-Tox Inc. (086900.KQ)
KRW 124900.0
(-2.42%)
KRW 124900.0
(-2.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 221.12 Billion | 195.09 Billion | 184.86 Billion | 140.82 Billion | 205.9 Billion | 205.44 Billion |
| Cost of Revenue | 92.95 Billion | 70.95 Billion | 82.41 Billion | 69.54 Billion | 72.18 Billion | 56.9 Billion |
| Gross Profit | 128.16 Billion | 124.13 Billion | 102.45 Billion | 71.28 Billion | 133.71 Billion | 148.53 Billion |
| Operating Expenses | 110.88 Billion | 77.69 Billion | 69.31 Billion | 108.35 Billion | 108.02 Billion | 63.36 Billion |
| Selling, General and Administrative Expenses | 61.43 Billion | 52.9 Billion | 44.83 Billion | 74.4 Billion | 79.78 Billion | 43.17 Billion |
| Research and Development Expenses | 25.13 Billion | 23.54 Billion | 23.26 Billion | 32.54 Billion | 27.01 Billion | 19.39 Billion |
| Other Expenses | 29.97 Billion | -1.24 Billion | -1.21 Billion | -1.4 Billion | -1.22 Billion | -796.84 Million |
| Cost and Expenses | 203.84 Billion | 148.65 Billion | 151.73 Billion | 177.89 Billion | 180.21 Billion | 120.27 Billion |
| Operating Income | 17.32 Billion | 46.44 Billion | 33.13 Billion | -37.06 Billion | 25.68 Billion | 85.17 Billion |
| Interest Expense | 2.33 Billion | 2.31 Billion | 4.78 Billion | 4.17 Billion | 2.08 Billion | 1.86 Billion |
| Income Tax Expense | 6.16 Billion | 12.93 Billion | 35 Billion | -12.1 Billion | -413.11 Million | 15.33 Billion |
| Earnings before Tax | 15.85 Billion | 52.74 Billion | 129.72 Billion | -39.7 Billion | 22.77 Billion | 85.09 Billion |
| Net Income | 9.75 Billion | 37 Billion | 94.15 Billion | -29.57 Billion | 26.2 Billion | 69.96 Billion |
| Earnings Per Share Basic | 1456.65 | 5491.68 | 14.58 Thousand | -4609.84 | 4050.83 | 11.11 Thousand |
| Earnings Per Share Diluted | 1456.65 | 5489.34 | 14.58 Thousand | -4609.84 | 4050.83 | 11.11 Thousand |
| Weighted Average Shares Outstanding | 6.69 Million | 6.56 Million | 6.38 Million | 6.41 Million | 6.46 Million | 6.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.69 Million | 6.56 Million | 6.38 Million | 6.41 Million | 6.46 Million | 6.29 Million |
| Gross Margin | 0.58 | 0.64 | 0.55 | 0.51 | 0.65 | 0.72 |
| EBIT Margin | 0.15 | 0.32 | 0.28 | -0.13 | 0.22 | 0.49 |
| Profit Margin | 0.04 | 0.19 | 0.51 | -0.21 | 0.13 | 0.34 |
| EBITDA | 32.69 Billion | 70.36 Billion | 51.39 Billion | -18.47 Billion | 44.27 Billion | 101.53 Billion |
| Earnings Before Tax Margin | 0.08 | 0.24 | 0.18 | -0.26 | 0.12 | 0.41 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 65 Billion | 54.58 Billion | 221.12 Billion | 68 Billion | 58.65 Billion | 51.78 Billion |
| Cost of Revenue | 24.41 Billion | 22.25 Billion | 92.95 Billion | 29.57 Billion | 21.89 Billion | 19.84 Billion |
| Gross Profit | 40.59 Billion | 32.33 Billion | 128.16 Billion | 38.43 Billion | 36.76 Billion | 31.94 Billion |
| Operating Expenses | 26.26 Billion | 33.26 Billion | 110.88 Billion | 36 Billion | 33.18 Billion | 22.39 Billion |
| Selling, General and Administrative Expenses | 17.46 Billion | 22.97 Billion | - | 28.28 Billion | 27.59 Billion | 17.25 Billion |
| Research and Development Expenses | 8.79 Billion | 10.29 Billion | - | 6.39 Billion | 5.59 Billion | 5.14 Billion |
| Other Expenses | -50.67 Billion | -55.51 Billion | -1.32 Billion | -1.32 Billion | -286.08 Million | -138.32 Million |
| Cost and Expenses | 50.67 Billion | 55.51 Billion | 203.84 Billion | 65.57 Billion | 55.07 Billion | 42.23 Billion |
| Operating Income | 14.33 Billion | -929.98 Million | 17.27 Billion | 2.42 Billion | 3.57 Billion | 9.55 Billion |
| Interest Expense | - | - | 2.33 Billion | 3.4 Billion | 382.9 Million | 1.72 Billion |
| Income Tax Expense | 2.54 Billion | 391.74 Million | 6.16 Billion | -1.23 Billion | 5.66 Billion | 708.39 Million |
| Earnings before Tax | 14.62 Billion | -107.43 Million | 21.42 Billion | -832.53 Million | 4.86 Billion | 10.55 Billion |
| Net Income | 11.41 Billion | -1.46 Billion | 9.75 Billion | -2.04 Billion | -2.32 Billion | 8.56 Billion |
| Earnings Per Share Basic | 1695.08 | -218.32 | - | -304.34 | -345.11 | 1273.00 |
| Earnings Per Share Diluted | 1695.08 | -363.00 | - | -304.34 | -345.11 | 1273.00 |
| Weighted Average Shares Outstanding | 6.73 Million | 6.73 Million | 6.69 Million | 6.73 Million | 6.72 Million | 6.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.73 Million | 4.04 Million | 6.69 Million | 6.73 Million | 6.72 Million | 6.72 Million |
| Gross Margin | 0.62 | 0.59 | 0.58 | 0.57 | 0.63 | 0.62 |
| EBIT Margin | 0.30 | 0.07 | - | 0.11 | 0.12 | 0.25 |
| Profit Margin | 0.18 | -0.03 | 0.04 | -0.03 | -0.04 | 0.17 |
| EBITDA | 19.59 Billion | 3.92 Billion | - | 7.23 Billion | 7.21 Billion | 13.03 Billion |
| Earnings Before Tax Margin | 0.22 | -0.02 | 0.08 | 0.04 | 0.06 | 0.18 |
HDIL
2424
TALK
8142
CUGCY
FGCO